| 12441801 |
Anti-VISTA antibodies and fragments, uses thereof, and methods of identifying same |
Gordon Powers, Enrique Zudaire Ubani, Douglas Matthew Marvel |
2025-10-14 |
|
| 12383543 |
Methods of treating prostate cancer |
Marco Gottardis, Rebecca Hawkins, Douglas H. Yamada |
2025-08-12 |
|
| 12188938 |
Anti-VISTA antibodies and fragments |
Gordon Powers, Manuel Sepulveda, John D. Alvarez |
2025-01-07 |
|
| 12139532 |
Anti-human vista antibodies and use thereof |
Jay Rothstein, Isabelle LeMercier, Gordon Powers |
2024-11-12 |
|
| 11992486 |
Methods of treating prostate cancer |
Marco Gottardis, Rebecca Hawkins, Douglas H. Yamada |
2024-05-28 |
$258,476,000 |
| 11987630 |
Anti-vista antibodies and fragments, uses thereof, and methods of identifying same |
Gordon Powers, Enrique Zudaire Ubani, Douglas Matthew Marvel |
2024-05-21 |
$175,597,000 |
| 11986469 |
Methods of treating prostate cancer |
Marco Gottardis, Rebecca Hawkins, Douglas H. Yamada |
2024-05-21 |
$175,597,000 |
| 11986470 |
Methods of treating prostate cancer |
Marco Gottardis, Rebecca Hawkins, Douglas H. Yamada |
2024-05-21 |
$175,597,000 |
| 11986468 |
Methods of treating prostate cancer |
Marco Gottardis, Rebecca Hawkins, Douglas H. Yamada |
2024-05-21 |
$175,597,000 |
| 11649283 |
Anti-human vista antibodies and use thereof |
Michael MOLLOY, Jay Rothstein, Dov PECHENICK, Gordon Powers |
2023-05-16 |
|
| 11603403 |
Anti-human vista antibodies and use thereof |
Isabelle LeMercier, Michael MOLLOY, Jay Rothstein, Gordon Powers |
2023-03-14 |
|
| 11603402 |
Anti-human vista antibodies and use thereof |
Catherine CARRIERE, Michael MOLLOY, Jay Rothstein, Gordon Powers |
2023-03-14 |
|
| 11525000 |
Anti-human VISTA antibodies and use thereof |
Michael MOLLOY, Jay Rothstein, Dov PECHENICK, Gordon Powers |
2022-12-13 |
|
| 11242392 |
Anti-vista antibodies and fragments |
Gordon Powers |
2022-02-08 |
$302,182,000 |
| 11207311 |
Method of treating prostate cancer |
Marco Gottardis, Rebecca Hawkins, Douglas H. Yamada |
2021-12-28 |
$192,233,000 |
| 11014987 |
Anti-vista antibodies and fragments, uses thereof, and methods of identifying same |
Gordon Powers, Enrique Zudaire Ubani, Douglas Matthew Marvel |
2021-05-25 |
$196,721,000 |
| 11009509 |
Anti-VISTA antibodies and fragments |
Gordon Powers, Manuel Sepulveda, John D. Alvarez |
2021-05-18 |
$96,075,000 |
| 10899836 |
Method of identifying anti-VISTA antibodies |
Gordon Powers, Enrique Zudaire Ubani, Douglas Matthew Marvel |
2021-01-26 |
$96,578,000 |
| 10730950 |
GITR antibodies, methods, and uses |
Cam Holland, John Kehoe, Alejandro Sepulveda, Daniel Villarreal |
2020-08-04 |
$103,352,000 |
| 10273301 |
Anti-vista antibodies and fragments |
Gordon Powers |
2019-04-30 |
$125,033,000 |
| 9206248 |
Vectors, host cells, and methods of production and uses |
Jill Carton, Jin Lu, Bernard Scallon |
2015-12-08 |
$65,625,000 |
| 8980626 |
Vectors, host cells, and methods of production and uses |
Jill Carton, Jin Lu, Bernard Scallon |
2015-03-17 |
$68,165,000 |
| 8663980 |
Vectors, host cells, and methods of production and uses |
Jill Carton, Jin Lu, Bernard Scallon |
2014-03-04 |
$70,665,000 |
| 8361474 |
Anti-IL-12 antibody based vectors, host cells, and methods of production and uses |
Jin Lu, Thomas Nesspor, Bernard Scallon |
2013-01-29 |
|
| 8138315 |
Anti-alpha V immunoliposome compositions, methods and uses |
Joshua Goldstein, Allen Magill, Deepak Saini, Raymond Sweet, Steve P. Weng |
2012-03-20 |
|
